Abiomed Announces Revenue of $38.3 Million, Up 19% and Record Impella Patient Usage, Up 26%

[at noodls] – DANVERS, Mass., Feb. 6, 2013 (GLOBE NEWSWIRE) — Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported third quarter fiscal 2013 revenue of $38.3 million, … more

View todays social media effects on ABMD

View the latest stocks trending across Twitter. Click to view dashboard

See who ABIOMED is hiring next, click here to view